Janus Henderson Group’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $194K | Sell |
13,000
-1,028,410
| -99% | -$15.4M | ﹤0.01% | 2323 |
|
|
2025
Q1 | $18.7M | Sell |
1,041,410
-415,330
| -29% | -$7.45M | 0.01% | 581 |
|
|
2024
Q4 | $33.9M | Buy |
1,456,740
+336,209
| +30% | +$7.83M | 0.02% | 473 |
|
|
2024
Q3 | $32.9M | Buy |
1,120,531
+446,664
| +66% | +$13.1M | 0.02% | 475 |
|
|
2024
Q2 | $15.9M | Buy |
673,867
+659,890
| +4,721% | +$15.6M | 0.01% | 611 |
|
|
2024
Q1 | $530K | Buy |
+13,977
| New | +$530K | ﹤0.01% | 1980 |
|